Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist
In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice i...
Gespeichert in:
| Veröffentlicht in: | European journal of endocrinology Jg. 169; H. 4; S. R81 |
|---|---|
| 1. Verfasser: | |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
01.10.2013
|
| Schlagworte: | |
| ISSN: | 1479-683X, 1479-683X |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients. |
|---|---|
| AbstractList | In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients.In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients. In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients. |
| Author | Shalet, S M |
| Author_xml | – sequence: 1 givenname: S M surname: Shalet fullname: Shalet, S M organization: Department of Endocrinology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23904274$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkM9LwzAcxYNM3A89eZccvVTzTbK0201G3dSBFwfeStp8p5U2qU06tv_ewibs9B6Px4fHG5OBdRYJuQX2AFPBHtPXNAIRMQnJBRmBjGeRSsTn4MwPydj7H8ZAScGuyJCLGZM8liNSp_uA1pc7pLhvsA2lR1paita4oi2tq9zXYU43b9QHbQukzlJtuirQ5Yq22FS6wBptmNPw3SMKZ11d-kB3_hicYfr4mlxudeXx5qQTsnlOPxaraP2-fFk8raMcYiWjbWwEGi6mCjFXElSxTSCfKjCALM-TXImZ1DzRMjEKtGYSwSgDOmYy4Qr5hNwfuU3rfjv0IetHFVhV2qLrfAZSCK6kEtBX707VLq_RZE1b1ro9ZP8X8T_BLGqc |
| CitedBy_id | crossref_primary_10_1016_S0140_6736_16_30053_8 crossref_primary_10_3310_nihropenres_14030_1 crossref_primary_10_1016_j_ghir_2015_03_001 crossref_primary_10_1210_er_2018_00092 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1530/EJE-13-0418 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1479-683X |
| ExternalDocumentID | 23904274 |
| Genre | Journal Article Review |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 5WD AABZA AACZT AAPGJ AAPXW AARHZ AAUAY AAVAP AAWDT ABDFA ABEJV ABGNP ABIME ABJNI ABMNT ABNHQ ABOCM ABPIB ABPQP ABPTD ABQNK ABSQV ABVGC ABWST ABXVV ABXZS ACFRR ACGFO ACNCT ACPRK ACUTJ ADBBV ADGKP ADIPN ADMTO ADNBA ADQBN ADVEK ADVOB AEMQT AENEX AFFNX AFGWE AFHIN AFXAL AFYAG AGQXC AGUTN AHMMS AI. AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALXQX ANFBD APJGH ATGXG BAWUL BCRHZ BTFSW C1A CGR CS3 CUY CVF DU5 E3Z EBS ECM EIF EJD EMOBN F9R GX1 H13 HZ~ IL9 INIJC J5H KOP KQ8 L7B NPM O9- OAUYM OBFPC OBOKY OCZFY OJZSN OK1 OPAEJ OVD OWPYF P2P ROX SJN TBS TCN TEORI TMA TR2 VH1 W8F WOQ X7M ZGI ZXP 7X8 AJBYB NU- |
| ID | FETCH-LOGICAL-b1764-f7d3ed2356eeb6416cf81b561d1e0bb8b6394a28a48d61aa04e1d6d1a704826e2 |
| IEDL.DBID | 7X8 |
| ISSN | 1479-683X |
| IngestDate | Thu Oct 02 09:45:14 EDT 2025 Thu Apr 03 06:55:47 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b1764-f7d3ed2356eeb6416cf81b561d1e0bb8b6394a28a48d61aa04e1d6d1a704826e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://dx.doi.org/10.1530/EJE-13-0418 |
| PMID | 23904274 |
| PQID | 1433264631 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1433264631 pubmed_primary_23904274 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-Oct 20131001 |
| PublicationDateYYYYMMDD | 2013-10-01 |
| PublicationDate_xml | – month: 10 year: 2013 text: 2013-Oct |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | European journal of endocrinology |
| PublicationTitleAlternate | Eur J Endocrinol |
| PublicationYear | 2013 |
| SSID | ssj0016430 |
| Score | 2.051078 |
| SecondaryResourceType | review_article |
| Snippet | In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | R81 |
| SubjectTerms | Adult Dwarfism, Pituitary - drug therapy Dwarfism, Pituitary - economics Dwarfism, Pituitary - epidemiology Endocrinology - economics Human Growth Hormone - therapeutic use Humans Hypopituitarism - drug therapy Hypopituitarism - epidemiology Models, Econometric Prevalence United Kingdom - epidemiology |
| Title | Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23904274 https://www.proquest.com/docview/1433264631 |
| Volume | 169 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFA5uiBe3utSNCOItOFkmyfQiIq3iUjxY6K0kkwz04FRbLfrvfclMqRdB8DKHwEzCy5uXL2_7EDpLWe5plhuSGpcQoTNDjKWcMMGZYl4aZSNryYPqdnW_nz3VDrdJnVY5s4nRULtRHnzkFzQ02pJCcnr5-kYCa1SIrtYUGotomQOUCVqt-vMoApy2sSBSqIxIzft1fV7Kk4v2XZsEXgNB9e_YMp4xnY3_rm4TrdfoEl9V6rCFFny5jRpXJdysX77wOY75ntGRvo1WH-uwegO9tD_rRHYcO_4HgmY8LLEvYebxsHK9t3DvHgcsmXs8KnFs3IFvbvHYx7yu4GVsYYCT2Fe1zpN3PJ1UAz8-A8M7qNdpP1_fkpqHgViqpCCFctw7xlPpvZWA4PICwC4AL0d9Yq22gHKEYdoI7SQ1JhGeOumoUWAemPRsFy2Vo9LvIyxdwZUGI8CsBeigTeiHl7qkMJYbmidNdDqT7wAWGoIXpvSjj8lgLuEm2qs2afBaNeQYMJ4FyhBx8Ie3D9EaC4wWMR_vCC0X8Jf7Y7SST0G245OoQPDsPj1-AxLK0ME |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extensive+expertise+in+endocrinology%3A+UK+stance+on+adult+GH+replacement%3A+the+economist+vs+the+endocrinologist&rft.jtitle=European+journal+of+endocrinology&rft.au=Shalet%2C+S+M&rft.date=2013-10-01&rft.eissn=1479-683X&rft.volume=169&rft.issue=4&rft.spage=R81&rft_id=info:doi/10.1530%2FEJE-13-0418&rft_id=info%3Apmid%2F23904274&rft_id=info%3Apmid%2F23904274&rft.externalDocID=23904274 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-683X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-683X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-683X&client=summon |